BIBLIOGRAPHY
This new section of the site is dedicated to articles related to methyldopa, and provides detailed and analytical information for professional use.
These scientific documents focus primarily on its use, and cover specific areas such as medical studies, the latest clinical research and new advances taking place within the pharmaceutical industry.
If you cannot find a specific article in the chronological archives below, you can use the SEARCH box situated on the left hand column.
Multi-Matrix System Mesalamine: To Use or Not To Use (February).
Ann Pharmacother 2008 Jan;(): [Epub ahead of print]
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
Can J Gastroenterol 2007 Dec;21(12):827-34
Thiopurine drugs (azathioprine and 6-mercaptopurine) inhibit Mycobacterium paratuberculosis growth in vitro.
Antimicrob Agents Chemother 2007 Dec;(): [Epub ahead of print]
Complicated Crohn's-like colitis, associated with Hermansky-Pudlak syndrome, treated with Infliximab: a case report and brief review of the literature.
J Med Case Reports 2007 Dec;1(1):176 [Epub ahead of print]
Effectiveness of mesalamine and propolis in experimental colitis.
Adv Ther 2007 Sep-Oct;24(5):1085-97